This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants

NCT06736912 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: IN-114199 2.5mg or placebo
DRUG: IN-114199 10mg or placebo
DRUG: IN-114199 20mg or placebo
DRUG: IN-114199 40mg or placebo
DRUG: IN-114199 5mg or placebo

Sponsor

HK inno.N Corporation